Retatrutide
Triple GIP/GLP-1/glucagon agonist under active investigation
Retatrutide (LY3437943)
Retatrutide is a triple agonist of GLP-1, GIP, and glucagon receptors. Its triagonist profile allows investigation of energy regulation, fat mobilization, and glycemic control within a single compound.
A triple receptor agonist of GLP-1, GIP, and glucagon studied for energy expenditure and fat mobilization.
For Research Use Only
Not for human consumption, veterinary use, or any therapeutic applications. Purchase requires valid research credentials.
Purity
Purity Exceeds 99%
Storage
2–8°C
Form
Lyophilized
Grade
Research
Retatrutide Overview
A triple receptor agonist of GLP-1, GIP, and glucagon studied for energy expenditure and fat mobilization.
Specifications
| Composition | Retatrutide (LY3437943) |
|---|---|
| Molecular Formula | C221H342N46O68 |
| Half-Life | ~6 days |
| Purity | Purity Exceeds 99% |
| Available Sizes | 5mg, 10mg, 30mg |
| Storage | 2–8°C, protect from light |
| SKU | RT5 |
| Grade | Research / Laboratory use only |



